The paucity of data necessitates further research to elucidate the pathophysiological connection between depression and cardiac diseases in the presence of N-terminal pro-brain natriuretic peptide (NT ...

N末端B型利钠肽原（NT-proBNP）是目前心衰诊断和评估预后的最有价值的生物标志物，但临床上一部分心功能不全患者的NT-proBNP是正常的。 一项来自郑州大学第一附属医院的研究提示，与NT-proBNP升高的心衰患者相比，NT-proBNP正常的心功能不全患者再住院风险低 ...

研究发现，对于无症状重度主动脉瓣狭窄（AS）患者，基线氨基末端B型利钠肽前体（NT-proBNP）与超敏肌钙蛋白T（hs-cTnT）水平升高与临床事件发生率升高相关，但 无论基线心脏标志物的水平如何，早期应用SAPIEN 3瓣膜行经导管主动脉瓣置换术（TAVR）相较临床随访 ...

A new trial will commence for patients with HFrEF and elevated NT-proBNP. Perspective from Mary Norine Walsh, MD, MACC CHICAGO — An autologous point-of-care cell therapy for adults with ischemic ...

Department of Neurology, Medical University of Graz, Austria. (I.H., M. Kneihsl, S.F.-H., C.E., T.G.) Division of Neuroradiology, Vascular and Interventional ...

Results Change in N-terminal pro-B-type natriuretic peptide concentration (∆ NT-proBNP) at 12 months from diagnosis was the strongest predictor of ongoing mortality and was independent of both change ...

The diagnosis of CHF was based on the Framingham score for CHF plus echocardiographic evidence of systolic or diastolic dysfunction. Blood concentrations of BNP and NT-proBNP were measured by two ...

Where no observation is available within the last 75 minutes, the latest observation is shown in italics and coloured and removed from the table after 30 hours. Station names link to data for the ...

Increases in home-measured blood pressure (BP) and N-terminal pro–brain natriuretic peptide (NT-proBNP) levels, along with a decrease in the left ventricular ejection fraction (LVEF), were ...